State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, People's Republic of China.
Bioorg Med Chem. 2011 Aug 15;19(16):4730-8. doi: 10.1016/j.bmc.2011.06.088. Epub 2011 Jul 7.
A series of novel cinnamic acyl sulfonamide derivatives (9a-16e) have been designed and synthesized and their biological activities were also evaluated as potential tubulin polymerization inhibitors. Among all the compounds, 10c showed the most potent growth inhibitory activity against B16-F10 cancer cell line in vitro, with an IC(50) value of 0.8μg/mL. Docking simulation was performed to insert compound 10c into the crystal structure of tubulin at colchicine binding site to determine the probable binding model. Based on the preliminary results, compound 10c with potent inhibitory activity in tumor growth may be a potential anticancer agent.
设计并合成了一系列新型肉桂酰基磺酰胺衍生物(9a-16e),并对其作为潜在的微管聚合抑制剂的生物活性进行了评估。在所有化合物中,10c 对 B16-F10 癌细胞系的体外生长抑制活性最强,IC50值为 0.8μg/mL。进行了对接模拟,将化合物 10c 插入秋水仙碱结合位点的微管晶体结构中,以确定可能的结合模型。根据初步结果,具有肿瘤生长抑制活性的化合物 10c 可能是一种有潜力的抗癌药物。